The Klein Law Firm Announces a Class Action Filed on Behalf of Ohr Pharmaceutical, Inc. Shareholders and a Lead Plaintiff Deadline of April 16, 2018 (OHRP)
March 08, 2018 18:04 ET
|
The Klein Law Firm
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) who...
OHRP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Ohr Pharmaceutical, Inc. and a Lead Plaintiff Deadline of April 16, 2018
March 01, 2018 17:32 ET
|
The Law Offices of Vincent Wong
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of...
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) To Contact Brower Piven Before The Lead Plaintiff Deadline
February 15, 2018 16:30 ET
|
Brower Piven, A Professional Corporation
STEVENSON, Md., Feb. 15, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the...
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Ohr Pharmaceutical, Inc.
February 15, 2018 13:58 ET
|
Federman & Sherwood
OKLAHOMA CITY, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on February 14, 2018, a class action lawsuit was filed in the United States District Court for the Southern...
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ohr Pharmaceutical, Inc. (OHRP)
February 14, 2018 19:00 ET
|
Gainey McKenna & Egleston
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”) (NASDAQ:OHRP)...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Ohr Pharmaceutical, Inc. Investors and Sets a Lead Plaintiff Deadline of April 16, 2018 -- OHRP
February 14, 2018 15:22 ET
|
Levi & Korsinsky, LLP
NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) --
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired...
Ohr Pharmaceutical Announces Efficacy Results from the MAKO Study in Wet-AMD
January 05, 2018 06:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported topline...
Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results
December 15, 2017 07:00 ET
|
Ohr Pharmaceutical, Inc.
Management to Host a Conference Call and Webcast at 8:30 a.m. Eastern Time Today NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical...
Ohr Pharmaceutical to Present at the Dawson James 3rd Annual Small Cap Growth Conference
October 11, 2017 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings
August 08, 2017 16:01 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported...